无症状重度主动脉瓣狭窄患者主动脉瓣置换概念的演变
本研究分析2002至2020年272例无症状重度主动脉瓣狭窄且左心室射血分数≥50%行外科主动脉瓣置换术患者的长期结局,中位随访8.5年。术后1、5、10、15年生存率分别为100%、94%、84%、76%,与年龄性别匹配的美国一般人群预期生存相当。术前中重度左心室肥厚与生存受损相关(HR 2.32,95%CI 1.02-5.27,P=.045)。
要点
- 无症状重度主动脉瓣狭窄患者行SAVR后生存率与年龄性别匹配的一般人群预期生存相当。
- 术前中重度左心室肥厚与生存受损相关,风险比2.32(95%CI 1.02-5.27,P=.045)。
- 术前平均E/E'≥14者术后舒张功能持续异常,E/E'晚期升高超过正常上限。
核心结论
- 在无症状主动脉瓣狭窄患者中,SAVR可恢复生存并改善左心室肥厚,但术前存在舒张功能障碍者术后残留持续功能障碍。
- 术前中重度左心室肥厚转化为生存受损。
- 这项观察性研究支持在该人群发生左心室肥厚之前早期行SAVR,尽管需要进一步研究。
研究设计与样本
- 回顾性分析2002年至2020年272例无症状重度主动脉瓣狭窄且左心室射血分数≥50%、行SAVR伴或不伴同期主动脉手术并符合研究标准的患者。
- 中位随访8.5年(四分位距6-12.8年),共2584患者年。
- 利用594份术后超声心动图评估左心室质量指数(LVMI)和平均E/E'的时间变化过程。
- 采用Cox比例风险模型评估术前LVMI和平均E/E'与生存的关联。
主要发现
- 无手术死亡。
- 纵向分析中,术前存在中重度左心室肥厚的患者LVMI改善。
- 平均E/E'早期下降后出现晚期升高至超过正常上限,尤其在术前平均E/E'≥14的患者中。
- 术后1、5、10、15年生存率分别为100%、94%、84%、76%,与基于美国一般人群的年龄性别匹配预期生存相当。
- 校正Cox生存分析中,仅中重度左心室肥厚与生存受损相关(HR 2.32,95%CI 1.02-5.27,P=.045)。
关键数值与推荐
- 术前中重度左心室肥厚与生存受损相关:HR 2.32(95%CI 1.02-5.27,P=.045)。
- 术后生存率:1年100%、5年94%、10年84%、15年76%。
- 术前平均E/E'≥14的患者术后平均E/E'晚期升高至超过正常上限。
临床怎么用
- 作者认为这项观察性研究支持在无症状重度主动脉瓣狭窄患者发生左心室肥厚之前早期行SAVR,尽管需要进一步研究。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Surgical treatment of asymptomatic severe aortic stenosis (AS) has been gaining attention ever since the results of the Early Surgery Versus Conventional Treatment in Very Severe Aortic Stenosis (RECOVERY) and Aortic Valve replacement versus conservative treatment in Asymptomatic seveRe aortic stenosis (AVATAR) trials showed survival benefits with early surgical aortic valve replacement (SAVR). This study analyzed the long-term clinical and echocardiographic outcomes of SAVR in asymptomatic severe AS. METHODS: Between 2002 and 2020, 272 patients with asymptomatic severe AS and a left ventricular ejection fraction ≥50% underwent SAVR with or without concomitant aortic surgery and met the study criteria. The median follow-up was 8.5 years (interquartile range, 6-12.8 years), for a total of 2584 patient-years. The time course of the left ventricular mass index (LVMI) and the average E/E' (ratio of the Doppler-derived E wave to the tissue Doppler-derived E' wave) were assessed using 594 postoperative echocardiograms. The association of preoperative LVMI and average E/E' with survival was assessed using Cox proportional hazards. RESULTS: There was no operative mortality. On longitudinal analyses, LVMI improved in patients who presented with moderate or severe preoperative left ventricular hypertrophy (LVH). However, after the early decline in average E/E', there was a late increase to greater than upper limit normal, particularly in patients with a preoperative average E/E'≥14. Postoperative survival was 100%, 94%, 84%, and 76% at 1, 5, 10, and 15 years, respectively, comparable to age- and sex-matched expected survival on the basis of the US general population. On adjusted Cox survival analysis, only moderate to severe LVH was associated with a survival penalty (hazard ratio], 2.32; 95% CI, 1.02-5.27; P = .045). CONCLUSIONS: In asymptomatic patients with AS, SAVR restores survival and improves LVH, but patients with diastolic dysfunction are left with persistent dysfunction. Presentation with moderate or severe LVH at the time of surgery translated to a survival penalty. This observational study supports early SAVR in this population before development of LVH, although further investigation is needed.
引用
- Javadikasgari H, McGurk S, Newell PC, et al. Evolving Concept of Aortic Valve Replacement in Asymptomatic Patients With Severe Aortic Stenosis. Ann Thorac Surg. 2023. PMID: 37660965. doi:10.1016/j.athoracsur.2023.08.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。